China's Sinopharm Says On Quest For $759 Million In Acquisitions
This article was originally published in PharmAsia News
Executive Summary
Sinopharm Group of China was only making the first of $759 million in planned acquisitions when it paid $197 million for a majority stake in LRT Pharma